These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 24687413)
1. The role of polymorphisms of genes CXCL12/CXCR4 and MIF in the risk development IBD the Polish population. Mrowicki J; Przybylowska-Sygut K; Dziki L; Sygut A; Chojnacki J; Dziki A; Majsterek I Mol Biol Rep; 2014 Jul; 41(7):4639-52. PubMed ID: 24687413 [TBL] [Abstract][Full Text] [Related]
2. Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis. Falvey JD; Bentley RW; Merriman TR; Hampton MB; Barclay ML; Gearry RB; Roberts RL World J Gastroenterol; 2013 Oct; 19(39):6656-64. PubMed ID: 24151396 [TBL] [Abstract][Full Text] [Related]
3. Contribution of the -173 G/C polymorphism of macrophage migration inhibitory factor gene to the risk of inflammatory bowel diseases. Przybyłowska K; Mrowicki J; Sygut A; Narbutt P; Dziki Ł; Dziki A; Majsterek I Pol Przegl Chir; 2011 Feb; 83(2):76-80. PubMed ID: 22166284 [TBL] [Abstract][Full Text] [Related]
4. MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling. Klasen C; Ohl K; Sternkopf M; Shachar I; Schmitz C; Heussen N; Hobeika E; Levit-Zerdoun E; Tenbrock K; Reth M; Bernhagen J; El Bounkari O J Immunol; 2014 Jun; 192(11):5273-84. PubMed ID: 24760155 [TBL] [Abstract][Full Text] [Related]
5. CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune system. Dotan I; Werner L; Vigodman S; Weiss S; Brazowski E; Maharshak N; Chen O; Tulchinsky H; Halpern Z; Guzner-Gur H Inflamm Bowel Dis; 2010 Apr; 16(4):583-92. PubMed ID: 19774645 [TBL] [Abstract][Full Text] [Related]
6. Association of T Helper 1 Cytokine Gene Single Nucleotide Polymorphisms with Ulcerative Colitis and Crohn's Disease. Ebrahimi Daryani N; Sadr M; Soltani S; Saghazadeh A; Moossavi S; Shahkarami S; Farhadi E; Rezaei N Dig Dis; 2019; 37(1):21-32. PubMed ID: 30134230 [TBL] [Abstract][Full Text] [Related]
7. The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma. Mazur G; Gębura K; Gieryng A; Butrym A; Wróbel T; Bogunia-Kubik K Cytokine; 2013 Oct; 64(1):422-6. PubMed ID: 23711392 [TBL] [Abstract][Full Text] [Related]
8. Association of the-801G/A polymorphism of CXCL12 gene with the risk of inflammatory bowel diseases development in a Polish population. Mrowicki J; Przybyłowska K; Dziki L; Sygut A; Wiśniewska-Jarosińska M; Chojnacki J; Dziki A; Majsterek I Pol Przegl Chir; 2011 Jun; 83(6):334-8. PubMed ID: 22166550 [TBL] [Abstract][Full Text] [Related]
9. Association of MIF-173 gene polymorphism with inflammatory bowel disease in Chinese Han population. Fei BY; Lv HX; Yang JM; Ye ZY Cytokine; 2008 Jan; 41(1):44-7. PubMed ID: 18054247 [TBL] [Abstract][Full Text] [Related]
10. Association of the macrophage migration inhibitory factor gene--173G/C polymorphism with inflammatory bowel disease: a meta-analysis of 4296 subjects. Zhang H; Ma L; Dong LQ; Shu C; Xu JL Gene; 2013 Sep; 526(2):228-31. PubMed ID: 23707797 [TBL] [Abstract][Full Text] [Related]
11. Association of Macrophage Migration Inhibitory Factor Polymorphisms with Total Plasma IgE Levels in Patients with Atopic Dermatitis in Korea. Kim JS; Choi J; Hahn HJ; Lee YB; Yu DS; Kim JW PLoS One; 2016; 11(9):e0162477. PubMed ID: 27598332 [TBL] [Abstract][Full Text] [Related]
12. Influence of MIF polymorphisms on CpG island hyper-methylation of CDKN2A in the patients with ulcerative colitis. Sakurai N; Shibata T; Nakamura M; Takano H; Hayashi T; Ota M; Nomura-Horita T; Hayashi R; Shimasaki T; Ostuka T; Tahara T; Arisawa T BMC Med Genet; 2020 Oct; 21(1):201. PubMed ID: 33046033 [TBL] [Abstract][Full Text] [Related]
13. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia. Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875 [TBL] [Abstract][Full Text] [Related]
14. Significance of the genetic polymorphism of CYP2D6 and NAT2 in patients with inflammatory bowel diseases. Dudarewicz M; Rychlik-Sych M; Barańska M; Wojtczak A; Trzciński R; Dziki A; Skrętkowicz J Pharmacol Rep; 2014 Aug; 66(4):686-90. PubMed ID: 24948072 [TBL] [Abstract][Full Text] [Related]
15. CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer. Guembarovski AL; Guembarovski RL; Hirata BKB; Vitiello GAF; Suzuki KM; Enokida MT; Watanabe MAE; Reiche EMV Mol Biol Rep; 2018 Oct; 45(5):741-750. PubMed ID: 29926386 [TBL] [Abstract][Full Text] [Related]
16. Association of MIF promoter polymorphisms with psoriasis in a Han population in northeastern China. Wu J; Chen F; Zhang X; Li Y; Ma H; Zhou Y; Jin Y; Wang H; Bai J; Zhang G; Fu S J Dermatol Sci; 2009 Mar; 53(3):212-5. PubMed ID: 19157791 [TBL] [Abstract][Full Text] [Related]
17. Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. Naderi N; Farnood A; Habibi M; Derakhshan F; Balaii H; Motahari Z; Agah MR; Firouzi F; Rad MG; Aghazadeh R; Zojaji H; Zali MR J Gastroenterol Hepatol; 2008 Dec; 23(12):1816-22. PubMed ID: 18752562 [TBL] [Abstract][Full Text] [Related]
18. The association of MYO9B gene in Italian patients with inflammatory bowel diseases. Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996 [TBL] [Abstract][Full Text] [Related]
20. The role of polymorphisms of stromal-derived factor-1 and CXC receptor 4 in acute myeloid leukemia and leukemia cell dissemination. Zheng Q; Shuai X; Ye Y; Jin Y; Jiang N; Chen X; Su J Gene; 2016 Aug; 588(2):103-8. PubMed ID: 27154815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]